Valeant announces new board of directors member
Valeant Pharmaceuticals International, Inc. announced Tuesday the addition of D. Robert Hale, partner of ValueAct Capital, to its board of directors and the resignation of Jeffrey W. Ubben, CEO and CIO of ValueAct Capital, effective as of Aug. 19. Read More »
Alerts Sign-up